Truist raised the firm’s price target on Intuitive Surgical to $375 from $320 and keeps a Buy rating on the shares. Intuitive Surgical remains one of the firm’s preferred large-caps and Truist believes China and Bariatric headwinds ultimately are manageable and transient, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ISRG:
- Intuitive Surgical price target raised to $330 from $300 at Morgan Stanley
- Robotics Stocks: Bot is Man’s Best Friend
- Intuitive Surgical Stock (NYSE:ISRG): Waiting For a Discount Might be Futile
- These are the Stocks Most Negatively Correlated to Treasury Yields
- Intuitive Surgical (NASDAQ:ISRG) Gains after Analyst Approval
